Your Position: News > Company News > SARS-CoV-2 Antigen Rapid Test obtains CE mark for self-testing

SARS-CoV-2 Antigen Rapid Test obtains CE mark for self-testing

CreateDate:2022-05-24

We are pleased to inform that Biohit (Hefei) hasobtained CE mark for our SARS-CoV-2 Antigen Rapid Test (Colloidal Gold Method) froma European Notified Body to be used as a consumer self-test in the EuropeanUnion (EU)!

 

This Test is a lateral flow assay for rapid,qualitative detection of SARS-CoV-2 virus. A nasal swab is used for collectionof specimens from individuals. Test results are delivered in as early as 15minutes with no instrumentation.

 

CE mark provides another important validation for theTest, allowing us to bring affordable, reliable tests closer to home formore consumers in the EU.